Breaking Science in Breast Cancer with Matteo Lambertini – ESMO
ESMO shared on X/Twitter:
“For ESMO members: Breaking Science in Breast Cancer.
Matteo Lambertini discusses the safety of assisted fertility after breast cancer in young BRCA carriers.
Catch this informative video and others on OncologyPRO now.”
Source: ESMO/X
Matteo Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital and the University of Genova in Italy.
He specializes in managing breast cancer in young women, particularly addressing fertility and pregnancy-related issues post-diagnosis. Lambertini’s notable research includes using GnRH agonists during chemotherapy to preserve ovarian function and studying the safety of pregnancy after breast cancer.
He also serves on the scientific boards of ESMO, ESHRE, and AIOM for fertility preservation in cancer patients.
The European Society for Medical Oncology (ESMO) represents over 35,000 oncology professionals across 172 countries and is a key resource for oncology education and information.
ESMO’s primary mission is to enhance the quality of cancer care, spanning prevention, diagnosis, palliative care, and patient follow-up.
It focuses on educating doctors, cancer patients, and the general public about best practices and the latest advancements in oncology, and advocates for equal access to optimal cancer care for all patients.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023